Human Genome Epidemiology Literature Finder
|
Records 1 - 2 (of 2 Records) |
| Query Trace: Achievement and KIR3DL1[original query] |
|---|
| Allelic Polymorphisms of KIRs and HLAs Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML. Cancer immunology research 2018 Apr . Ureshino Hiroshi, Shindo Takero, Kojima Hiroto, Kusunoki Yasushi, Miyazaki Yuki, Tanaka Hidenori, Saji Hiroh, Kawaguchi Atsushi, Kimura Shin |
| IFN-? treatment may enable discontinuation of TKIs in NK cell-licensed patients with CML-CP. EJHaem 2024 12 5 (6): 1278-1282. Hiroshi Ureshino, Kazuharu Kamachi, Keisuke Kidoguchi, Shinya Kimu |
- Page last reviewed:Feb 1, 2024
- Content source: